MarketCap
Facebook
X
TelegramQuartalsbericht 2026-Q1
hinzugefügt 07.05.2026
Charles River Laboratories International Anteile 2011-2026 | CRL
Anteile Jährlich Charles River Laboratories International
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49.6 M | 51.4 M | 51.2 M | 50.8 M | 50.3 M | 49.6 M | 49.7 M | 49 M | 48.6 M | 47 M | 47.6 M | 47.6 M | 48.5 M | 48.4 M | 50.8 M | 62.6 M | 65.4 M | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 65.4 M | 47 M | 51.1 M |
Anteile Vierteljährlich Charles River Laboratories International
| 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 49 M | 49.2 M | 49.1 M | 50.7 M | 51.1 M | 51.4 M | 51.6 M | 51.4 M | 51.3 M | 51.3 M | 51.2 M | 51.1 M | 50.9 M | 50.9 M | 50.8 M | 50.6 M | 50.5 M | 50.4 M | 50.3 M | 50 M | 49.8 M | 49.7 M | 49.6 M | 49.2 M | 48.9 M | 48.8 M | 48.8 M | 48.5 M | 48.2 M | 48.3 M | 48.2 M | 47.8 M | 47.4 M | 47.5 M | 47.6 M | 47.5 M | 47.4 M | 47.2 M | 47.1 M | 46.6 M | 46.7 M | 46.3 M | 46.7 M | 46.8 M | 47.3 M | 46 M | 46.9 M | 47.1 M | 47.6 M | 47.9 M | 48.3 M | 47.7 M | 48.9 B | 47.6 M | 48 M | 48.3 M | 48.9 M | 50.1 M | 51 M | 53.9 M | 57.7 M | 66.3 M |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 48.9 B | 46 M | 837 M |
Anteile anderer Aktien in der Diagnostik & Forschung
| Name | Anteile | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
20.9 M | - | -6.23 % | $ 30.6 M |  Germany |
 |
Co-Diagnostics
CODX
|
1.33 M | $ 1.32 | -19.02 % | $ 1.76 M |  USA |
 |
Agilent Technologies
A
|
304 M | $ 112.31 | -0.84 % | $ 34.1 B | USA |
 |
Castle Biosciences
CSTL
|
29 M | $ 19.54 | 3.5 % | $ 566 M | USA |
|
Akumin
AKU
|
89.5 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
Fulgent Genetics
FLGT
|
30.2 M | $ 15.85 | -2.1 % | $ 479 M | USA |
 |
Aspira Women's Health
AWH
|
34.1 M | - | -6.19 % | $ 10.5 M | USA |
 |
Accelerate Diagnostics
AXDX
|
82.2 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
17 M | - | -13.05 % | $ 7.29 M | USA |
 |
Illumina
ILMN
|
159 M | $ 140.5 | -1.91 % | $ 22.3 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
26.6 M | - | - | $ 562 M |  Britain |
 |
Interpace Biosciences
IDXG
|
4.42 M | $ 1.8 | - | $ 7.96 M | USA |
 |
CareDx, Inc
CDNA
|
53.3 M | $ 19.85 | -3.12 % | $ 1.06 B | USA |
 |
Chembio Diagnostics
CEMI
|
32.3 M | - | 0.22 % | $ 16.8 M | USA |
 |
Check-Cap Ltd.
CHEK
|
6.23 M | - | - | $ 9.42 M |  Israel |
 |
HTG Molecular Diagnostics
HTGM
|
889 K | - | -20.0 % | $ 1.06 M | USA |
 |
Lantheus Holdings
LNTH
|
67.5 M | $ 94.39 | -2.36 % | $ 6.37 B | USA |
 |
Medpace Holdings
MEDP
|
28.8 M | $ 419.67 | 0.12 % | $ 12.1 B | USA |
 |
Global Cord Blood Corporation
CO
|
122 M | - | - | $ 399 M |  China |
 |
Mettler-Toledo International
MTD
|
20.6 M | $ 1 053.18 | 1.08 % | $ 21.7 B |  Schweiz |
 |
Fluidigm Corporation
FLDM
|
74.3 M | - | 1.08 % | $ 308 M | USA |
 |
Myriad Genetics
MYGN
|
92.6 M | $ 3.63 | 0.14 % | $ 336 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
461 M | - | 0.12 % | $ 80.1 M | China |
 |
NeoGenomics
NEO
|
128 M | $ 8.28 | -0.96 % | $ 1.06 B | USA |
 |
DermTech
DMTK
|
32.6 M | - | -11.32 % | $ 2.94 M | USA |
 |
National Research Corporation
NRC
|
22.4 M | $ 18.68 | -1.29 % | $ 418 M | USA |
 |
Natera
NTRA
|
98.4 M | $ 187.81 | -4.62 % | $ 18.5 B | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
63.8 M | - | - | $ 10.7 B | USA |
 |
Enzo Biochem
ENZ
|
50.9 K | - | -8.98 % | $ 14.8 K | USA |
 |
Exact Sciences Corporation
EXAS
|
189 M | - | - | $ 19.8 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
948 M | $ 25.3 | -0.82 % | $ 24 B |  Niderland |
 |
Guardant Health
GH
|
125 M | $ 93.62 | -5.11 % | $ 11.7 B | USA |
 |
Personalis
PSNL
|
89.2 M | $ 6.53 | -2.68 % | $ 583 M | USA |
 |
Heska Corporation
HSKA
|
10.3 M | - | - | $ 1.31 B | USA |
 |
Senseonics Holdings
SENS
|
41.7 M | $ 5.74 | -1.37 % | $ 240 M | USA |
 |
ICON Public Limited Company
ICLR
|
82.5 M | $ 117.02 | -0.06 % | $ 9.65 B |  Irlanda |
 |
Soleno Therapeutics
SLNO
|
50.8 M | $ 52.99 | - | $ 2.69 B | USA |
 |
QIAGEN N.V.
QGEN
|
217 M | - | - | $ 10.6 B | Niderland |
 |
Biomerica
BMRA
|
2.3 M | $ 2.33 | -3.32 % | $ 5.35 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
83.2 M | $ 251.91 | -0.83 % | $ 21 B | USA |
 |
Thermo Fisher Scientific
TMO
|
377 M | $ 441.56 | -1.47 % | $ 166 B | USA |
 |
Trinity Biotech plc
TRIB
|
359 M | $ 0.56 | -3.84 % | $ 201 M | Irlanda |
 |
Celcuity
CELC
|
46.8 M | $ 135.89 | 0.86 % | $ 6.35 B | USA |
 |
Motus GI Holdings
MOTS
|
1.55 M | - | -34.28 % | $ 263 K | Israel |
 |
Twist Bioscience Corporation
TWST
|
59.8 M | $ 49.5 | -6.52 % | $ 2.96 B | USA |
 |
Neogen Corporation
NEOG
|
217 M | $ 8.28 | -1.84 % | $ 1.8 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
111 M | $ 187.84 | -0.05 % | $ 20.9 B | USA |
 |
Invitae Corporation
NVTA
|
236 M | - | - | $ 21.2 M | USA |